HUMA
USDHumacyte Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$1.300
High
$1.340
Low
$1.220
Volume
3.25M
Company Fundamentals
Market Cap
249.1M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
5.40M
Exchange
NMS
Currency
USD
52-Week Range
Related News
BTIG Maintains Buy on Humacyte, Lowers Price Target to $6
BTIG analyst Ryan Zimmerman maintains Humacyte with a Buy and lowers the price target from $7 to $6.
Humacyte Announces Pricing of $60.0 Million Oversubscribed Registered Direct Offering
DURHAM, N.C., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today
D. Boral Capital Maintains Buy on Humacyte, Maintains $25 Price Target
D. Boral Capital analyst Jason Kolbert maintains Humacyte with a Buy and maintains $25 price target.
Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus
– Patent covers esophagus produced using Humacyte's proprietary bioengineered regenerative tissue platform, designed for implant in patients with damaged esophagus –
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.